ESTHEMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID7010362843

KRS0000626748

Share capital5,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. GRÓJECKA 214 / U9, 02-390 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

ESTHEMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. GRÓJECKA 214 / U9, 02-390 WARSZAWA

Show on map

NIP

7010362843

REGON

146442101

KRS

0000626748

Legal form

limited liability company

Register Address

UL. GRÓJECKA 214 / U9, 02-390 WARSZAWA

Date of registration in KRS

2016-07-04

Date of commencement of economic activity

2016-07-04

Act signature

RDF/708097/25/738

Pkd codes

86.23.Z - Dental practice

46.46.Z - Wholesale trade of pharmaceutical and medical products

47.7 - Retail sale of other products excluding motor vehicles, including motorcycles

47.73.Z - Retail sale of pharmaceutical products

47.75 - Retail sale of cosmetics and toiletries

86.21.Z - General medical practice

86.22.Z - Specialist medical practice

86.90.A - Healthcare

86.90.C - Healthcare

86.90.E - Healthcare

Payer VAT status

exempted

Vat list bank account(s)

PL03 1950 0001 2006 0028 9437 0002

PL65 1020 1055 0000 9002 0334 6848

Company authorities

representation authorityMANAGEMENT

representation type

OŚWIADCZENIA W IMIENIU SPÓŁKI MOGĄ BYĆ SKŁADANE JEDNOOSOBOWO PRZEZ KAŻDEGO CZŁONKA ZARZĄDU

MANAGEMENT

Dariusz Czesław Dutkiewicz

Member Of The Board, 51 years old

shareholders

Dariusz Czesław Dutkiewicz

100% 100 udziałów o łącznej wartości 5.000 złotych

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	K PLN	K PLN	K PLN	%
Assets	691,2	677	838,3	23,8
Gross profit (loss)	-124,8	2,7	221	7949,3
EBITDA	-100,2	20,2	238,5	1080,4
Net profit (loss)	-124,8	2,7	221	7949,3
Cash	51,4	43,6	233,9	436,2
Liabilities and provisions for liabilities	618,8	481,9	422,2	-12,4
Net income from sale	719,3	770,4	870,7	13
Short time liabilities	171,5	66,7	58,3	-12,6
Working assets	70,8	74,1	252,8	241,2
Equity capital	72,4	195,1	416,1	113,3
Operating profit (EBIT)	-124,8	2,7	221	7949,3
Depreciation	24,7	17,5	17,5	0
	%	%	%	p.p.
Profitability of capital	-172,5	1,4	53,1	51,7
Equity capital to total assets	10,5	28,8	49,6	20,8
Gross profit margin	-17,4	0,4	25,4	25
EBITDA Margin	-13,9	2,6	27,4	24,8
	Days	Days	Days	Days
Short term commitment turnover cycle	87	32	24	-8